Longevity Programs

Longevity medicine is one of the fastest-growing disciplines in clinical practice — and one of the most misunderstood. At Advanced Vitality Group, we approach longevity not as a wellness trend but as a rigorous medical specialty grounded in peer-reviewed research. Our programs are designed to extend healthspan — the years of life spent in genuine good health, free from chronic disease, cognitive decline, and functional limitation — using only interventions supported by published clinical evidence.

The difference between longevity medicine and conventional healthcare is not about exotic therapies or anti-aging supplements with unverified claims. It is about timing. Conventional medicine responds to disease after it develops. Longevity medicine intervenes earlier — at the level of the biological processes that cause disease to develop in the first place.

In 2013, a landmark paper by López-Otín and colleagues published in Cell identified a framework called the hallmarks of aging — a set of interconnected biological processes that collectively drive the functional decline we associate with getting older. This framework was updated in 2023 to include 12 hallmarks, ranging from genomic instability and telomere shortening to cellular senescence, mitochondrial dysfunction, and chronic low-grade inflammation.

What this research established is that aging is not inevitable in the way we once assumed. These hallmarks are measurable, and to varying degrees, they are modifiable. The goal of a longevity program is to identify which of these processes are most active in an individual patient — using biomarker testing — and to apply evidence-based interventions to slow or counteract them.

Longevity medicine is not a one-time intervention — it is an ongoing, data-driven process. Biomarkers are retested at regular intervals, typically every three to six months in the first year, then annually as the program matures. This allows us to confirm that interventions are producing the intended biological changes, identify any new areas of concern, and adjust protocols based on your response.

The biomarkers we track span multiple domains. On the hormonal side, we monitor testosterone, estradiol, IGF-1, thyroid hormones, and DHEA-S. Metabolically, we follow fasting insulin, HbA1c, and the HOMA-IR score as a measure of insulin resistance. For inflammation, hs-CRP and IL-6 are the primary targets. For cellular health, NAD+ levels and GDF-15 provide insight into mitochondrial function and senescence burden. Nutritionally, we track vitamin D, omega-3 index, B12, magnesium, and zinc — all of which play roles in aging pathways that are easy to overlook.

The longevity space is flooded with products, protocols, and promises that have no credible scientific support. At Advanced Vitality Group, we hold ourselves to a strict standard: every intervention we recommend must be supported by data from peer-reviewed clinical trials, systematic reviews, or established medical guidelines. Sources we rely on include PubMed-indexed journals, the NIH, the FDA, the Endocrine Society, and the American Urological Association.

This means we will tell you clearly when evidence is strong, when it is emerging, and when a therapy remains investigational. We do not use scientific-sounding language to obscure weak evidence. We do not recommend supplements because they are trending. If an intervention does not have credible human clinical data, we say so — and we explain what the current evidence does and does not support.